Shafira Meidyana

ORCID: 0000-0001-6047-7669 · 5 papers in corpus
observational 2026
Reproduction & fertility ·doi:10.1530/RAF-24-0109

ABSTRACT: Endometriosis, with a global prevalence of approximately 18%, is a chronic condition that significantly impacts patients' quality of life and increases the risk of depression. Despite growing public health concerns, access to heal…

meta-analysis 2024
·doi:10.1142/s2661318224500075

Background: To date, diagnosis is still a challenge in managing endometriosis. There is a need to develop a less invasive yet accurate approach, such as a biomarker, to help diagnose endometriosis earlier and more precisely. Metabolomics, t…

meta-analysis 2024
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2024.01.038

IMPORTANCE: This systematic review supports the involvement of the WNT4 gene in the pathophysiology of endometriosis. OBJECTIVE: To conduct a systematic review and meta-analysis on WNT4 rs7521902 and rs16826658 polymorphism associated with…

meta-analysis 2023
·doi:10.1142/s2661318223743680

Background: Endometriosis is a chronic disease that affects approximately 10% of reproductive-age women, and one of the primary symptoms is pain, which can significantly impact quality of life and productivity. This has resulted in substant…

review 2023
·doi:10.15562/bmj.v12i1.3816

Endometriosis is one of the most frequent abnormalities in women with infertility. Endocrine disruptors, such as dioxin, are considered to affect the development of endometriosis. Various studies have been done to find an association betwee…